Clinical Trial Update: A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating doxycycline vs standard supportive therapy in newly diagnosed Cardiac AL Amyloidosis patients receiving bortezomib-based therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Al Amyloidosis

Drugs mentioned

• Bortezomib (bortezomib)
• Doxycycline (Doxycycline)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Cardiac AL Amyloidosis | Phase 2, Phase 3 | Status: TERMINATED